A Phase 1 Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine
Clinical trial NCT06113744 · UNKNOWN
Trial details
- NCT number
- NCT06113744
- Sponsor
- CNBG-Virogin Biotech (Shanghai) Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-10
- Primary completion
- 2023-06-30
- Enrollment
- 164
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.